Protein profiling in pathology: Analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas

Proteomics - Clinical Applications

Volumn 4, Issue 5, 2010, Pages 519-527

  Jansen, Corine ^a   Feuth, Ton ^b   Raemaekers, John M M ^a   Rijntjes, Jos ^a   Meijer, Jos W ^c   Westenend, Pieter J ^d   van Baarlen, Joop ^e   van Krieken, Johan H J M ^a   Hebeda, Konnie M ^a   Groenen, Patricia J T A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d Laboratory for Pathology Dordrecht   (Netherlands)

^e Laboratory for Pathology East Netherlands   (Netherlands)

Author keywords

Data analysis; Lymphoma; MS; Pathology; Protein profiling

Indexed keywords

CYCLIN D1; PROTEIN HYDROLYSATE;

ARTICLE; B CELL LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

HUMANS; HYPERPLASIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LOGISTIC MODELS; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, MANTLE-CELL; NEOPLASM PROTEINS; PROTEIN ARRAY ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EQUUS ASINUS;

EID: 77953737426     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900120     Document Type: Article

References (19)

1. Issaq, H. J., Veenstra, T. D., Conrads, T. P., Felschow, D., The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 2002, 292, 587-592.
2. Li, Y., Dang, T. A., Shen, J., Perlaky, L. et al., Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma. Proteomics 2006, 6, 3426-3435.
3. Roesch-Ely, M., Nees, M., Karsai, S., Ruess, A. et al., Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 2007, 26, 54-64.
4. Suriano, R., Lin, Y., Ashok, B. T., Schaefer, S. D. et al., Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases. J. Proteome Res. 2006, 5, 856-861.
5. Ward, D. G., Suggett, N., Cheng, Y., Wei, W. et al., Identification of serum biomarkers for colon cancer by proteomic analysis. Br. J. Cancer 2006, 94, 1898-1905.
6. Zinkin, N. T., Grall, F., Bhaskar, K., Out, H. H. et al., Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin. Cancer Res. 2008, 14, 470-477.
7. Escher, N., Spies-Weisshart, B., Kaatz, M., Melle, C. et al., Identification of HNP3 as a tumour marker in CD41 and CD4-lymphocytes of patients with cutaneous T-cell lymphoma. Eur. J. Cancer 2006, 42, 249-255.
8. Fan, G., Molstad, M., Braziel, R. M., Standley, M. et al., Proteomic profiling of mature CD101 B-cell lymphomas. Am. J. Clin. Pathol. 2005, 124, 920-92z9.
9. Lin, Z., Jenson, S. D., Lim, M. S., Elenitoba-Johnson, K. S., Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma. Mod. Pathol. 2004, 17, 670-678.
10. Miguet, L., Bogumil, R., Decloquement, P., Herbrecht, R. et al., Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS. J. Proteome Res. 2006, 5, 2258-2269.
11. Qi, L., Cazares, L., Johnson, C., de, A. P. et al., Serum protein expression profiling in pediatric Hodgkin lymphoma: a report from the Children's Oncology Group. Pediatr. Blood Cancer 2008, 51, 216-221.
12. Zhang, X., Wang, B., Zhang, X. S., Li, Z. M. et al., Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning. BMC Cancer 2007, 7,235.
13. Jansen, C., Hebeda, K. M., Linkels, M., Grefte, J. M. et al., Protein profiling of B-cell lymphomas using tissue biopsies: A potential tool for small samples in pathology. Cell Oncol. 2008, 30, 27-38.
14. Federation of medical Scientific Societies. Code for proper secondary use of human tissue in The Netherlands. Federa 2002.
15. Harrell, F. E., Leave-one-out cross-validation, Regression Modeling Strategies, Springer-Verlag, New York Inc., 2001.
16. Draminski, M., Rada-Iglesias, A., Enroth, S., Wadelius, C. et al., Monte Carlo feature selection for supervised classification. Bioinformatics 2008, 24, 110-117.
17. Hummel, M., Bentink, S., Berger, H., Klapper, W. et al., A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 2006, 354, 2419-2430.
18. Goy, A., Stewart, J., Barkoh, B. A., Remache, Y. K. et al., The feasibility of gene expression profiling generated in fineneedle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma. Cancer 2006, 108, 10-20.
19. Dave, S. S., Wright, G., Tan, B., Rosenwald, A. et al., Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 2004, 351, 2159-2169.